Literature DB >> 14747530

Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells.

Julia E Dooher1, Jaisri R Lingappa.   

Abstract

Previously we have described a stepwise, energy-dependent pathway for human immunodeficiency virus type 1 (HIV-1) capsid assembly in a cell-free system. In this pathway, Gag polypeptides utilize the cellular factor HP68 and assemble into immature capsids by way of assembly intermediates that have defined biochemical characteristics. Here we address whether this pathway is universally conserved among primate lentiviruses and can be observed in mammalian cells. We demonstrate that HIV-2 Gag associates with human HP68 in a cell-free system and that Gag proteins of HIV-2, simian immunodeficiency virus SIVmac239, and SIVagm associate with endogenous HP68 in primate cells, as is seen for HIV-1. Analysis of primate cells expressing lentivirus Gag proteins revealed Gag-containing complexes with the same sedimentation values as seen for previously described HIV-1 assembly intermediates in the cell-free system (10S, 80-150S, and 500S). These complexes fit criteria for assembly intermediates as judged by energy sensitivity, pattern of HP68 association, and the failure of specific complexes to be formed by assembly-incompetent Gag mutants. We also demonstrate that virus-like particles released from cells do not appear to contain HP68, suggesting that HP68 is released from Gag upon completion of capsid assembly in cells, as was observed previously in the cell-free system. Together these findings support a model in which all primate lentivirus capsids assemble by a conserved pathway of HP68-containing, energy-dependent assembly intermediates that have specific biochemical features.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747530      PMCID: PMC369511          DOI: 10.1128/jvi.78.4.1645-1656.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Origins and evolution of AIDS viruses: estimating the time-scale.

Authors:  P M Sharp; E Bailes; F Gao; B E Beer; V M Hirsch; B H Hahn
Journal:  Biochem Soc Trans       Date:  2000-02       Impact factor: 5.407

Review 2.  The road taken: past and future foundations of membrane traffic.

Authors:  I Mellman; G Warren
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

4.  A conformational switch controlling HIV-1 morphogenesis.

Authors:  I Gross; H Hohenberg; T Wilk; K Wiegers; M Grättinger; B Müller; S Fuller; H G Kräusslich
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.

Authors:  L S Ehrlich; B E Agresta; C A Carter
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation.

Authors:  J B Jowett; D J Hockley; M V Nermut; I M Jones
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

10.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.

Authors:  J Luban; K L Bossolt; E K Franke; G V Kalpana; S P Goff
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

View more
  30 in total

1.  The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.

Authors:  Fei Guo; Shan Cen; Meijuan Niu; Yiliang Yang; Robert J Gorelick; Lawrence Kleiman
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 2.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

3.  HIV Gag-leucine zipper chimeras form ABCE1-containing intermediates and RNase-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Motoko Tanaka; Veronica T Nguyen; Samina Giri; Jaisri R Lingappa
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 4.  New insights into HIV assembly and trafficking.

Authors:  Muthukumar Balasubramaniam; Eric O Freed
Journal:  Physiology (Bethesda)       Date:  2011-08

5.  A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.

Authors:  Bridget A Robinson; Jonathan C Reed; Clair D Geary; J Victor Swain; Jaisri R Lingappa
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Authors:  Brook C Barajas; Motoko Tanaka; Bridget A Robinson; Daryl J Phuong; Kasana Chutiraka; Jonathan C Reed; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2018-04-17       Impact factor: 6.823

7.  Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.

Authors:  Jonathan C Reed; Nick Westergreen; Brook C Barajas; Dylan T B Ressler; Daryl J Phuong; John V Swain; Vishwanath R Lingappa; Jaisri R Lingappa
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

8.  Characterization of a myristoylated, monomeric HIV Gag protein.

Authors:  Jun Dou; Jaang-Jiun Wang; Xuemin Chen; Hua Li; Lingmei Ding; Paul Spearman
Journal:  Virology       Date:  2009-03-12       Impact factor: 3.616

9.  An excess of rare genetic variation in ABCE1 among Yorubans and African-American individuals with HIV-1.

Authors:  D C Crawford; N Zheng; E C Speelmon; I Stanaway; M J Rieder; D A Nickerson; M J McElrath; J Lingappa
Journal:  Genes Immun       Date:  2009-08-06       Impact factor: 2.676

10.  Host-rabies virus protein-protein interactions as druggable antiviral targets.

Authors:  Usha F Lingappa; Xianfu Wu; Amanda Macieik; Shao Feng Yu; Andy Atuegbu; Michael Corpuz; Jean Francis; Christine Nichols; Alfredo Calayag; Hong Shi; James A Ellison; Emma K T Harrell; Vinod Asundi; Jaisri R Lingappa; M Dharma Prasad; W Ian Lipkin; Debendranath Dey; Clarence R Hurt; Vishwanath R Lingappa; William J Hansen; Charles E Rupprecht
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.